Share the full article
ModifyHealth, based near Atlanta, launched in 2018 to treat patients with diet-related diseases with ‘food as medicine.’ Dietary management is recommended for chronic conditions including type 2 diabetes, irritable bowel syndrome, and heart and kidney diseases.
“ModifyHealth’s commitment to making food as medicine simple, accessible and sustainable aligns seamlessly with our mission,” said Rachel Roller of the Dohmen Company Foundation, which led ModifyHealth’s Series C round through its Dohmen Impact Investment Fund.
Investing in health
ModifyHealth aims to make “telenutrition and medically tailored meal support a standard of care,” says CEO GB Pratt. The financing will help the company expand live nutrition coaching and remote patient monitoring, as well as partnerships with healthcare providers and employers.
ModifyHealth offers individual customers subscription plans for meals costing from $10 to $14. Backers in the new round include RC Capital and Nashville Capital Network.
